ChromaDex, Inc.
ChromaDex, Inc.
Explore linked clinical trials.5 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Milk Volume Outcomes Following Oral Nicotinamide Riboside Supplementation in Mothers of Extremely Preterm Infants | Female Urogenital Diseases and Pregnancy Complications, Obstetric Labor Complications, Obstetric Labor, Premature, Premature Birth, Urogenital Diseases, pregnancy disorder | Recruiting | Phase 2 / Phase 3 | 2026-09-14 | NCT04614714 | |
| Efficacy of Topical Niacinamide Riboside on the Signs of Facial Skin Aging | Fine Lines and Wrinkles; Skin Aging on Face; Skin Care; Skin Care Dermocosmetics | Recruiting | Not applicable | 2026-08-21 | NCT07774000 | |
| Randomized, Open-label, Safety Study of Subcutaneous and Intramuscular Injections of Niagen® Plus | Fatigue, Pathological Conditions, Signs and Symptoms, Signs and Symptoms | Recruiting | Phase 1 | 2025-11-26 | NCT07251608 | |
| Absorption and Tolerability of Injectable Administration of Niagen®+, as Compared to NAD+ | Healthy Aging | Recruiting | Not applicable | 2025-04-09 | NCT06919328 | |
| Nicotinamide Riboside and Prevention of Cancer Therapy Related Cardiac Dysfunction in Breast Cancer Patients | Cardiotoxicity, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, cardiovascular disorder, heart disorder, heart failure, injury, neoplasm, radiation injury, skin disorder | Recruiting | Phase 2 | 2023-03-17 | NCT05732051 |